The effect of quadriple regimen on the eradication rate of Helicobacter pylori
- Conditions
- En Helicobacter pylori.Helicobacter pylori [H.pylori] as the cause of diseases classified to other chaptersB98.0
- Registration Number
- IRCT20080901001155N32
- Lead Sponsor
- Rasht University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 420
Positive Helicobacter pylori in the endoscopy
No therapeutic regimen for treatment
People over the age of 18 years
Pregnant and breast feeding women
Gastric and esophageal malignancy
Cirrhosis and Diabetes
heart and kidney failure
History of seizure, hematologic diseases
Immune system deficiency
Drug sensitivity including Pentoprazole and Lactobacillus routeri
Patients with incomplete treatment
With acute gastrointestinal disease (such as acute diarrhea)
Chronic gastrointestinal disease (such as inflammatory bowel disease and celiac disease)
Kidney failure
Nervous disease and those who received antibiotics or acidblocking drugs 6 weeks ago
Use of nonsteroidal antiinflammatory drugs (NSAIDs) such as aspirin 3 weeks before treatment or in the past month for any reason
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Helicobacter pylori eradication. Timepoint: 8 weeks after the end of the treatment. Method of measurement: En Ureas Breath Test with C14.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.